Benitec Biopharma Inc. (BNTC) vs Sanara MedTech Inc. (SMTI)

A side-by-side comparison of Benitec Biopharma Inc. and Sanara MedTech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BNTC vs SMTI

growth of $100 · dividends reinvested · last 10y
BNTC -97.4% (-30.5%/yr)SMTI +775.0% (+24.2%/yr)SMTI compounded faster over this window
Log scale — wide-divergence pair
01101001k10kStart $10020182020202220242026$3$875
BNTC SMTI

BNTC vs SMTI: by the numbers

  • •SMTI is the larger company ($322M vs $309M market cap).
  • •Both run net losses; BNTC's is the smaller (0.00% vs -29.15% net margin).

Metrics side by side

Valuation

MetricBNTCSMTI
Forward P/EN/A184.21
P/S ratioN/A2.93
P/B ratio1.7540.51
EV / EBITDAN/A27.80
FCF yieldN/A1.40%

Profitability

MetricBNTCSMTI
Gross margin0.00%91.33%
Operating margin0.00%9.36%
Net margin0.00%-29.15%
ROE-25.73%-403.03%
ROIC-28.88%18.15%

Growth (annualized)

MetricBNTCSMTI
Revenue CAGR (5Y)N/A40.06%
Total return CAGR (5Y)-31.08%0.35%

Frequently asked

How have BNTC and SMTI total returns compared?
Over the past 10 years, BNTC delivered -30.49% and SMTI delivered 24.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.